The fasting blood glucose, triglyceride, alanine aminotransferase (ALT) and hypersensitive C-reactive protein (hs-CRP) levels in the CAD group were significantly higher than in the control group (P < 0.05). The gene discussed is GPT; the disease is coronary artery disorder.